BioReliance Corporation is a leading provider of cost-effective contract services to the pharmaceutical and biopharmaceutical industries, offering more than 1,000 tests or services.
Location: United States, Maryland, Rockville
Founded date: 1947
Investors 1
| Date | Name | Website |
| - | Avista Cap... | avistacap.... |
Mentions in press and media 10
| Date | Title | Description |
| 15.09.2020 | Merck Expands BioReliance® Viral Clearance Offering in Singapore, Saving Customers Time | Allows customers to continue developing lifesaving medicines amid Covid-19 pandemic Customers can view the lab studies “live” with Merck scientists SINGAPORE – Media OutReach – 15 September 2020 – Merck, a leading science and technology com... |
| 09.01.2012 | Avista Capital Partners agrees to sell BioReliance to Sigma-Aldrich Corporation | Rockville, MD, USA – January 9, 2012 – BioReliance, a leading provider of global biopharmaceutical testing services, announced today that it has agreed to be acquired by Sigma-Aldrich Corporation (NASDAQ:SIAL). Avista Capital Partners, the ... |
| 17.12.2007 | Avista Capital Partners Agrees To Acquire Bristol-Myers Squibb Medical Imaging For Approximately $525 Million | New York, NY, December 17, 2007 – Bristol-Myers Squibb Company (NYSE: BMY) and Avista Capital Partners, a leading private equity firm, announced today the parties have signed a definitive agreement for Avista to acquire Bristol-Myers Squibb... |
| 13.12.2007 | Boston Scientific Agrees to Sell Fluid Management And Venous Access Business To Avista Capital Partners for $425 Million | Natick, MA and New York, NY December 13, 2007 – Boston Scientific Corporation (NYSE: BSX) and Avista Capital Partners, a leading private equity firm, today jointly announced the signing of a definitive agreement under which Avista will acqu... |
| 03.12.2007 | David A. Dodd to Lead BioReliance Corporation | Rockville, MD, December 3, 2007 – (BUSINESS WIRE) — BioReliance Corporation announced today that David A. Dodd has been named President, Chief Executive Officer and Chairman of the Board of the Company, effective today. BioReliance Corporat... |
| 17.10.2007 | Avista Capital Partners bolsters healthcare practice with appointments of Charles Harwood and Ron Sparks | New York, NY, October 17, 2007 – Avista Capital Partners, a leading private equity firm, today announced that it has hired Charles C. Harwood, Jr., a proven operator in the clinical diagnostics and pharmaceutical services industries, and Ro... |
| 13.06.2007 | Avista Capital Partners Raises $2.0 Billion Inaugural Fund | New York, NY, June 13, 2007 – Avista Capital Partners, a leading middle market focused private equity firm, announced today that it has completed the final closing of its first private equity fund, Avista Capital Partners, L.P. (the “Fund”)... |
| 12.04.2007 | Avista Capital Partners completes acquisition Of Bioreliance Corporation from Invitrogen Corporation | New York, NY, April 12, 2007 – Avista Capital Partners, a leading private equity firm, announced today it has completed its acquisition of BioReliance Corporation, a business unit of Invitrogen Corporation (NASDAQ: IVGN) for approximately $... |
| 13.02.2007 | Avista Capital Partners agrees to acquire Bioreliance Corporation for approximately $210 million | New York, NY, February 13, 2007 – Avista Capital Partners, a leading private equity firm, announced today it has signed a definitive agreement to acquire BioReliance Corporation, a business unit of Invitrogen Corporation (NASDAQ: IVGN) for ... |
| - | Avista Capital Partners Appoints Hakan Bjorklund As Healthcare Operating Executive | Departing Nycomed CEO Bolsters Leading Private Equity Healthcare Practice New York, NY, October 3, 2011 – Avista Capital Partners, a leading private equity firm, today announced that it has hired Håkan Björklund, the departing Chief Execut... |